'FDA Rescinds Juul Ban, Opening Door For Federal Clearance; E-Cigarette Maker's Products Have Stayed On Market Pending Appeal Of 2022 Ban' - WSJ
Portfolio Pulse from Benzinga Newsdesk
The FDA has rescinded its ban on Juul e-cigarettes due to new case law, opening the possibility for federal clearance of Juul products.
June 06, 2024 | 2:44 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
22nd Century Group (XXII), a company focused on reduced nicotine tobacco, may face increased competition due to the FDA's decision on Juul.
22nd Century Group focuses on reduced nicotine tobacco products. The FDA's decision to allow Juul back into the market could increase competition, potentially impacting XXII's market share.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 60
NEUTRAL IMPACT
Philip Morris International (PM) might experience indirect effects from the FDA's decision on Juul, as it operates in the same industry.
While Philip Morris International does not have a direct stake in Juul, the regulatory environment for e-cigarettes can impact the broader tobacco industry.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50
POSITIVE IMPACT
Altria Group (MO), which has a significant stake in Juul, may benefit from the FDA's decision to rescind the ban on Juul e-cigarettes.
Altria Group owns a significant stake in Juul. The FDA's decision to rescind the ban on Juul e-cigarettes could lead to increased sales and revenue for Juul, thereby benefiting Altria.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 80